Clinical trial update: implications and management of residual disease after neoadjuvant therapy for breast cancer
-
* Corresponding author: Erica L Mayer emayer@partners.org
Breast Cancer Research 2007, 9:110 doi:10.1186/bcr1755
Accesses
- Last 30 days: 40 accesses
- Last 365 days: 454 accesses
- All time: 2890 accesses